Clinical Trials Directory

Trials / Conditions / B-Cell Prolymphocytic Leukemia

B-Cell Prolymphocytic Leukemia

9 registered clinical trials studyying B-Cell Prolymphocytic Leukemia.

StatusTrialSponsorPhase
CompletedLetermovir for the Prevention of Cytomegalovirus Reactivation in Patients With Hematological Malignancies Trea
NCT04312841
Ohio State University Comprehensive Cancer CenterPhase 2
Active Not RecruitingPevonedistat and Ibrutinib in Treating Participants With Relapsed or Refractory CLL or Non-Hodgkin Lymphoma
NCT03479268
City of Hope Medical CenterPhase 1
CompletedEntospletinib and Obinutuzumab in Treating Patients With Relapsed Chronic Lymphocytic Leukemia, Small Lymphocy
NCT03010358
Alexey Danilov, MDPhase 1 / Phase 2
UnknownCAR-T Cell Immunotherapy in CD19 Positive Relapsed or Refractory Leukemia and Lymphoma
NCT02819583
PersonGen BioTherapeutics (Suzhou) Co., Ltd.Phase 1 / Phase 2
UnknownPCAR-119 Bridge Immunotherapy Prior to Stem Cell Transplant in Treating Patients With CD19 Positive Leukemia a
NCT02892695
PersonGen BioTherapeutics (Suzhou) Co., Ltd.Phase 1 / Phase 2
UnknownStudy Evaluating the Efficacy and Safety of PCAR-019 in CD19 Positive Relapsed or Refractory Leukemia and Lymp
NCT02851589
PersonGen BioTherapeutics (Suzhou) Co., Ltd.Phase 1 / Phase 2
Active Not RecruitingCellular Immunotherapy Following Chemotherapy in Treating Patients With Recurrent Non-Hodgkin Lymphomas, Chron
NCT02153580
City of Hope Medical CenterPhase 1
CompletedAutologous Peripheral Blood Stem Cell Transplant Followed by Donor Bone Marrow Transplant in Treating Patients
NCT01008462
Fred Hutchinson Cancer CenterPhase 2
CompletedFludarabine Phosphate and Total-Body Irradiation Before Donor Peripheral Blood Stem Cell Transplant in Treatin
NCT00060424
Fred Hutchinson Cancer CenterPhase 2